Treating additional colon cancer cells with Kyn also promoted AHR nuclear translocation (Fig. 6H) and induced the expression of the canonical of AHR target gene CYP1A1 (Fig. 6I). This evidence concerns the gene CYP1A1 and malignant colon neoplasm.